期刊文献+

CA19-9、CA125和CEA联合检测在AFP阴性的ICC鉴别诊断中的效果 被引量:1

Effect of Combined Detection of CA19-9 and CA125 and CEA in Differential Diagnosis of AFP Negative ICC
下载PDF
导出
摘要 目的:探究CA19-9(血清癌抗原19-9)、CA125(癌抗原125)和CEA(癌胚抗原)联合检测在AFP(甲胎蛋白)阴性的ICC(肝内胆管细胞癌)鉴别诊断中的效果。方法:收集某院2015年12月~2017年12月收治的92例ICC患者,根据AFP的阳阴性,分甲组(阴性组n=46)和乙组(阳性组n=46)。用微粒子酶联免疫分析法对CEA、CA125、CA19-9进行检测,比较血清肿瘤标记物及其诊断效能。结果:与乙组CEA、CA125、CA19-9水平比较,甲组较高,具有统计学差异,P<0.05;根据CEA、CA125、CA19-9截断点可知CEA的正确率、特异度、灵敏度分别是60.9%、65.2%、59.2%;CA125的分别是65.2%、69.6%、56.5%,CA19-9的分别是68.5%、76.1%、60.9%。结论:AFP阴性的ICC患者进行CEA、CA125、CA19-9检测,可有效提高ICC患者的诊断准确率,效果确切,值得借鉴。 Objective:To explore the effect of combined detection of CA19-9 and CA125 and CEA in differential diagnosis of AFP negative ICC.Methods:92 cases of ICC patients treated in a hospital from December 2015 to December 2017 were collected and divided into the group A(negative group,n=46)and group B(positive group,n=46)according to AFP.The CEA,CA125 and CA19-9 were tested with microparticle enzyme-linked immunoassay,and the serum tumor markers and their diagnostic efficacy were compared.Results:The level of levels of CEA,CA125 and CA19-9 in group A were higher than those in group B,with statistical difference(P〈0.05).According to the cut-off points of CEA,CA125 and ca19-9,the accuracy,specificity and sensitivity of CEA was 60.9%,65.2%and 59.2%respectively.The accuracy,specificity and sensitivity was 65.2%,69.6% and 56.5% respectively,while the accuracy,specificity and sensitivity was68.5%,76.1%and 60.9%respectively.Conclusion:The detection of CEA,CA125 and ca19-9 in the ICC patients with AFP negative can effectively improve the diagnostic accuracy of ICC patients,which the effect is exact and worth learning.
作者 李翠芬 Li Cuifen(Department of Clinical Laboratory ,Anyang People's Hospital, Henan Province ,Anyang 45500)
出处 《数理医药学杂志》 2018年第5期675-676,共2页 Journal of Mathematical Medicine
关键词 肝内胆管细胞癌 甲胎蛋白 癌胚抗原 癌抗原125 血清癌抗原19-9 intrahepaticcholangiocarcinoma alpha-fetoprotein carcinoembryonic antigen cancer antigen 125 serum carcinoantigen 19-9
  • 相关文献

参考文献6

二级参考文献60

  • 1Wan-Yee Lau,Eric C. H. Lai.Hepatocellular carcinoma: current management and recent advances[J].Hepatobiliary & Pancreatic Diseases International,2008,7(3):237-257. 被引量:102
  • 2韦佩佳.老年复发卵巢癌患者预后影响因素[J].中国老年学杂志,2014,34(8):2081-2082. 被引量:10
  • 3Ukaszewicz-Zajac M,Mroczko B,Kozlowski M,et al.Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma[J].Pol Arch Med Wewn,2009,119(9):558-563.
  • 4Mehta J,Prabhu R,Eshpunigani P,et al.Evaluating the efficacy of tumor markers CA19-9 and CEA to predict operability and survival in pancreatic malignancies[J].Trop Gastroenterol,2010,31(3):190-194.
  • 5Jnntermanns B,Radunz S,Heuer M,et al.Tumor markers as a diagnostic key for hilar cholangiocarcinoma[J].Eur J Med Res,2010,15(8):357-361.
  • 6Chen Y, Zhang L, Liu WX, et al. Prognostic significance of preoperative anemia, leukocytosis and thrombocytosis in Chinese women with epithelial ovarian cancer[J]. Asian Pac J Cancer Prey, 2015, 16(3):933-939.
  • 7Ozaksit G, Tokmak A, Kalkan H, et al. Value of the platelet to lymphocyte ratio in the diagnosis of ovarian neoplasms inadolescents[J]. Asian Pac J Cancer Prev, 2015, 16(5):2037- 2041.
  • 8Wang S, Akbas R, Demirci U. Microchip ELISA coupled with cell phone to detect ovarian cancer HE4 biomarker in urine[J]. Methods Mol Biol, 2015, 1256:111-121.
  • 9Gasiorowska E, Michalak M, Warchoi W, et al. Clinical application of HE4 and CA125 in ovarian cancer type I and type II detection and differential diagnosis[J]. Ginekol Pol, 2015.86(2:88-93.
  • 10许沈华,凌雨田,朱赤红,等.外周血肿瘤标志物检测在胃癌患者长期生存的意义[J].中国病理生理杂志,2015,17(10):1845.

共引文献74

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部